tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Silvan Tuerkcan, 176 are a BUY (96.17%), 7 are a HOLD (3.83%).
Analyst Silvan Tuerkcan, currently employed at JMP, carries an average stock price target met ratio of 38.87% that have a potential upside of 43.19% achieved within 117 days.
Silvan Tuerkcan’s has documented 356 price targets and ratings displayed on 26 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CRSP, Crispr Therapeutics AG at 23-Dec-2025.
Analyst best performing recommendations are on NUVB (NUVATION BIO).
The best stock recommendation documented was for TERN (TERNS PHARMACEUTICALS) at 10/23/2025. The price target of $15 was fulfilled within 13 days with a profit of $7.5 (100%) receiving and performance score of 76.92.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 29-Jul-2025
$48
$4.04 (9.19%)
$44
10 days ago
(08-Jan-2026)
2/4 (50%)
$1.81 (3.92%)
91
Buy
Since 26-Sep-2023
$52
$8.04 (18.29%)
$46
10 days ago
(08-Jan-2026)
9/12 (75%)
$5.81 (12.58%)
128
Hold
Since 17-Dec-2024
$41
$-2.96 (-6.73%)
$46
13 days ago
(05-Jan-2026)
6/7 (85.71%)
$-2.58 (-5.92%)
63
Hold
Since 19-Sep-2024
$40
$-3.96 (-9.01%)
$38
2 months 12 days ago
(06-Nov-2025)
3/4 (75%)
$-0.8 (-1.96%)
24
Buy
Since 17-Sep-2018
$42
2 months 15 days ago
(03-Nov-2025)
14/14 (100%)
$9.2 (28.05%)
439
Which stock is Silvan Tuerkcan is most bullish on?
Which stock is Silvan Tuerkcan is most reserved on?
What Year was the first public recommendation made by Silvan Tuerkcan?
